Pfizer wants in on Summit’s goal to beat Keytruda via ADC combos
Pfizer wants a piece of the showdown with the world’s biggest medicine.
The New York pharma giant — facing an activist investor, shedding multiple parts of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
